Victory Capital Management Inc. Has $445.95 Million Holdings in Maximus, Inc. (NYSE:MMS)

Victory Capital Management Inc. lowered its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,317,817 shares of the health services provider's stock after selling 414,915 shares during the quarter. Maximus makes up approximately 0.5% of Victory Capital Management Inc.'s holdings, making the stock its 28th biggest holding. Victory Capital Management Inc. owned approximately 8.71% of Maximus worth $445,952,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Knights of Columbus Asset Advisors LLC grew its position in Maximus by 346.3% during the 4th quarter. Knights of Columbus Asset Advisors LLC now owns 118,290 shares of the health services provider's stock worth $9,920,000 after acquiring an additional 91,788 shares during the last quarter. DekaBank Deutsche Girozentrale boosted its position in Maximus by 501.4% in the 4th quarter. DekaBank Deutsche Girozentrale now owns 42,100 shares of the health services provider's stock valued at $3,511,000 after buying an additional 35,100 shares during the last quarter. DAVENPORT & Co LLC acquired a new stake in shares of Maximus in the 4th quarter valued at $1,157,000. Legato Capital Management LLC raised its position in shares of Maximus by 134.1% during the fourth quarter. Legato Capital Management LLC now owns 23,521 shares of the health services provider's stock worth $1,972,000 after acquiring an additional 13,474 shares during the last quarter. Finally, Graham Capital Management L.P. acquired a new position in shares of Maximus during the third quarter valued at $2,709,000. 97.21% of the stock is owned by institutional investors.


Maximus Trading Up 0.6 %

NYSE MMS traded up $0.49 on Wednesday, reaching $80.77. The company had a trading volume of 206,312 shares, compared to its average volume of 326,804. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71. Maximus, Inc. has a 52 week low of $72.39 and a 52 week high of $89.69. The stock has a market cap of $4.93 billion, a price-to-earnings ratio of 26.58 and a beta of 0.72. The stock's 50 day moving average is $82.38 and its 200-day moving average is $81.43.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, beating analysts' consensus estimates of $1.28 by $0.06. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 3.73% and a return on equity of 15.68%. Maximus's revenue for the quarter was up 6.2% on a year-over-year basis. During the same period last year, the company posted $0.94 EPS. Equities analysts predict that Maximus, Inc. will post 5.42 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Wednesday, May 15th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend is Tuesday, May 14th. Maximus's dividend payout ratio is currently 39.74%.

Insider Buying and Selling

In other Maximus news, CFO David Mutryn sold 8,000 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $83.95, for a total value of $671,600.00. Following the completion of the sale, the chief financial officer now directly owns 5,124 shares in the company, valued at $430,159.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts recently commented on MMS shares. StockNews.com upgraded Maximus from a "hold" rating to a "buy" rating in a research report on Thursday, February 8th. Raymond James lowered shares of Maximus from an "outperform" rating to a "market perform" rating in a report on Wednesday, January 3rd.

View Our Latest Report on Maximus

Maximus Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Read More

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)

Should you invest $1,000 in Maximus right now?

Before you consider Maximus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.

While Maximus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Search Headlines: